Procedure : 2018/2782(RSP)
Document stages in plenary
Document selected : O-000134/2018

Texts tabled :

O-000134/2018 (B8-0006/2019)

Debates :

PV 12/02/2019 - 22
CRE 12/02/2019 - 22

Votes :

Texts adopted :


Parliamentary questions
PDF 104kWORD 20k
28 November 2018
O-000134/2018

Question for oral answer O-000134/2018

to the Commission

Rule 128

Daniela Aiuto

on behalf of the Committee on Women's Rights and Gender Equality


  Subject:  Policy challenges and strategies against women's cancers and related comorbidities

 Answer in plenary 

One in three Europeans develops cancer during their lifetime and the Member States are not doing enough to fight it. Certain forms of cancer, such as breast, uterus and cervical cancer, exist predominantly among, or are exclusive to, women. What is more, breast cancer is the most common fatal cancer for women, not only in the EU but in the whole world. Data demonstrates that if women are diagnosed early with breast cancer and receive timely treatment, the survival rate can reach around 80%. This shows the importance of quality-assured, population-based screening. If women do succeed, however, in defeating cancer, often the struggle is not over, as they face serious and usually underestimated psychological problems –especially if they underwent a hysterectomy or mastectomy. Women and their family members should receive tailored support in the form of counselling.

Although widespread, these types of women’s cancers do not receive the attention they deserve from the public and policymakers. It is very difficult for women and their families to receive holistic treatment that meets all their needs. It is vitally important that women have easy access to screening programmes, affordable and equal treatment and support, help tailored to their specific situations and information on the lifestyle factors that can help prevent cancer.

Tabled: 28.11.2018

Forwarded: 30.11.2018

Deadline for reply: 7.12.2018

Last updated: 4 December 2018Legal notice